← Back to Search

Deep Brain Stimulation for Parkinson's Disease

N/A
Waitlist Available
Led By Mark R Richardson
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects 18-85 years old
Subjects scheduled for DBS implantation, as determined by the clinical multidisciplinary movement disorders board with definitive diagnosis of Parkinson's disease
Must not have
Non-English-speaking subjects
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of single dbs surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial will study brain activity in Parkinson's patients with deep brain stimulation to improve speech perception and production.

Who is the study for?
This trial is for English-speaking adults aged 18-85 with Parkinson's Disease who are scheduled for Deep Brain Stimulation (DBS) implantation. Participants must be able to understand the study and follow instructions.
What is being tested?
The study aims to gather data on brain activity related to speech in Parkinson's patients during DBS. Researchers will use this information to better understand how DBS affects speech perception and production.
What are the potential side effects?
Since the intervention involves collecting brain signal data rather than a medical treatment, traditional side effects are not applicable. However, there may be risks associated with standard DBS procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 85 years old.
Select...
I am scheduled for a DBS implant for my Parkinson's disease.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~duration of single dbs surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of single dbs surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The number of subjects providing interpretable electrophysiological data during DBS surgery

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Brain signal data collectionExperimental Treatment1 Intervention
Collection of brain data during deep brain stimulation

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,006 Previous Clinical Trials
13,307,252 Total Patients Enrolled
Mark R RichardsonPrincipal InvestigatorMGH
Mark R Richardson, MD, PhDPrincipal InvestigatorMGH

Media Library

Brain signal data collection Clinical Trial Eligibility Overview. Trial Name: NCT04277689 — N/A
Parkinson's Disease Research Study Groups: Brain signal data collection
Parkinson's Disease Clinical Trial 2023: Brain signal data collection Highlights & Side Effects. Trial Name: NCT04277689 — N/A
Brain signal data collection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04277689 — N/A
~1 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top